Literature DB >> 2303842

Effect of Pseudomonas cepacia colonization on survival and pulmonary function of cystic fibrosis patients.

L O Lewin1, P J Byard, P B Davis.   

Abstract

We conducted a historical prospective study of 124 cystic fibrosis (CF) patients colonized with Pseudomonas cepacia (cases) and 124 sex and age matched non-colonized CF patients (controls). Thirty-two of the colonized patients died in the first year following P. cepacia colonization compared to 8 of the control patients, a highly significant difference (p less than 0.001). In the second year, there was no significant difference in mortality between the two groups. Cases as a group had poorer pulmonary function and chest X-ray scores than controls up to 2 years before P. cepacia first appeared in their sputum or throat cultures. Regression analysis of pulmonary function tests (percent predicted FEV1 and RV/TLC) for each subject from 3 years before to 2 years after colonization revealed significant differences between cases and controls in slope for FEV1 and in slope and intercept for RV/TLC. When compared separately according to gender, the differences between cases and controls are significant in females but not in males. These results suggest that patients with poor pulmonary function are more prone to colonization with P. cepacia, that a subgroup of these patients will be dramatically affected and die within a year, and that the organism continues to exert a less dramatic negative effect on the pulmonary function of those patients who survive the initial acute effects of colonization, particularly in female patients.

Entities:  

Mesh:

Year:  1990        PMID: 2303842     DOI: 10.1016/0895-4356(90)90175-o

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  28 in total

Review 1.  Cystic fibrosis.

Authors:  P Robinson
Journal:  Thorax       Date:  2001-03       Impact factor: 9.139

2.  Individualised unsupervised exercise training in adults with cystic fibrosis: a 1 year randomised controlled trial.

Authors:  A J Moorcroft; M E Dodd; J Morris; A K Webb
Journal:  Thorax       Date:  2004-12       Impact factor: 9.139

3.  Cystic fibrosis, a Burkholderia cenocepacia chest wall abscess and rapid clinical deterioration.

Authors:  N J Simmonds; K M Gyi
Journal:  J R Soc Med       Date:  2008-07       Impact factor: 5.344

Review 4.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Exercise testing and prognosis in adult cystic fibrosis.

Authors:  A J Moorcroft; M E Dodd; A K Webb
Journal:  Thorax       Date:  1997-03       Impact factor: 9.139

6.  Impact of microbiology practice on cumulative prevalence of respiratory tract bacteria in patients with cystic fibrosis.

Authors:  M R Shreve; S Butler; H J Kaplowitz; H R Rabin; D Stokes; M Light; W E Regelmann
Journal:  J Clin Microbiol       Date:  1999-03       Impact factor: 5.948

7.  Accuracy of four commercial systems for identification of Burkholderia cepacia and other gram-negative nonfermenting bacilli recovered from patients with cystic fibrosis.

Authors:  D L Kiska; A Kerr; M C Jones; J A Caracciolo; B Eskridge; M Jordan; S Miller; D Hughes; N King; P H Gilligan
Journal:  J Clin Microbiol       Date:  1996-04       Impact factor: 5.948

8.  Field inversion gel electrophoresis on Pseudomonas cepacia strains isolated from cystic fibrosis patients.

Authors:  G Amalfitano; E Tonolli; F Favari; C Perazzoli; G Cazzola; G Mastella; I Piacentini
Journal:  Eur J Epidemiol       Date:  1996-04       Impact factor: 8.082

9.  Role of a 22-kilodalton pilin protein in binding of Pseudomonas cepacia to buccal epithelial cells.

Authors:  U S Sajjan; J F Forstner
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

10.  Epidemic of Pseudomonas cepacia in an adult cystic fibrosis unit: evidence of person-to-person transmission.

Authors:  D L Smith; L B Gumery; E G Smith; D E Stableforth; M E Kaufmann; T L Pitt
Journal:  J Clin Microbiol       Date:  1993-11       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.